GSK, AstraZeneca rivalry takes center stage at cancer conference

GlaxoSmithKline and AstraZeneca will each present trial data on a promising new class of drugs against ovarian cancer on Saturday as Britain's top drugmakers compete to burnish their oncology credentials.

from Reuters: Health News https://ift.tt/2mORqJy
via IFTTT